Capricor Therapeutics, Inc. (CAPR) Discusses HOPE-3 Open-Label Extension Data and Deramiocel Update for Duchenne Muscular Dystrophy - Slideshow

Capricor Therapeutics, Inc. (CAPR) discussed HOPE-3 data and Deramiocel update for Duchenne muscular dystrophy. No direct impact on seafarers.

Want to stay up to date with the world events at sea or at home?

Explore Navvyx News - the best News app for seafarers.